Correspondence to "Omalizumab Reduces Anaphylactic Reactions and Allows Food Introduction in Food-Allergic in Children With Severe Asthma: An Observational Study"

被引:0
作者
Klain, Angela [1 ]
Indolfi, Cristiana [1 ]
Grella, Carolina [1 ]
Colosimo, Simone [1 ]
Perrotta, Alessandra [1 ]
del Giudice, Michele Miraglia
机构
[1] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy
关键词
asthma; children; food allergy; omalizumab; prevention;
D O I
10.1111/all.16560
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:2
相关论文
共 6 条
[1]  
[Anonymous], 2024, FDA APPROVES 1 MEDIC
[2]   Omalizumab reduces anaphylactic reactions and allows food introduction in food-allergic in children with severe asthma: An observational study [J].
Arasi, Stefania ;
Cafarotti, Arianna ;
Galletta, Francesca ;
Panetta, Valentina ;
Riccardi, Carla ;
Calandrelli, Veronica ;
Fierro, Vincenzo ;
Dahdah, Lamia ;
Artesani, Maria Cristina ;
Valluzzi, Rocco Luigi ;
Pecora, Valentina ;
Tallarico, Valeria ;
Dinardo, Giulio ;
Scalzo, Lucia Lo ;
Fiocchi, Alessandro .
ALLERGY, 2025, 80 (04) :1074-1085
[3]   Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study [J].
Fiocchi, Alessandro ;
Artesani, Maria Cristina ;
Riccardi, Carla ;
Mennini, Maurizio ;
Pecora, Valentina ;
Fierro, Vincenzo ;
Calandrelli, Veronica ;
Dahdah, Lamia ;
Valluzzi, Rocco Luigi .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06) :1901-+
[4]  
Klain A., 2024, Ital. J. Pediatr. Allergy Immunol, V38, P14, DOI [10.53151/2531-3916/2024-508, DOI 10.53151/2531-3916/2024-508]
[5]   Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis [J].
Lieberman, Jay A. ;
Chehade, Mirna .
CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (01) :78-84
[6]   A randomized, double-blind placebo-controlled study on the efficacy of Omalizumab on food allergy threshold in children with severe food allergy [J].
Mortz, Charlotte G. ;
Parke, Louise ;
Rasmussen, Helene M. ;
Kjaer, Henrik Fomsgaard ;
Bindslev-Jensen, Carsten .
ALLERGY, 2024, 79 (04) :964-976